期刊文献+

儿童期系统性红斑狼疮疗效不佳的危险因素分析 被引量:3

The risk of poor response to treatment in juvenile-onset systemic lupus erythematosus patients
原文传递
导出
摘要 目的 探索儿童SLE出现疗效不佳的危险因素.方法 回顾性分析收治本院的儿童SLE初发患者的临床资料、诊治情况和随访资料,根据治疗6个月时的疗效,分为治疗有效组和疗效不佳组,应用SPSS 16.0软件对2组患儿进行分析比较,对计量资料进行t检验,对计数资料进行x2检验,然后对有统计学意义的单因素进行受试者工作(ROC)曲线分析,并作进一步的Logistic回归分析.结果 82例SLE初发患儿中,治疗有效组72例,疗效不佳组10例.疗效不佳组中男童更常见(5/10和12/72,χ2=5.937,P=0.015),浮肿的发生率更高(10/10和25/72,χ2=15.294,P<0.01),浆膜炎的发生率更高(8/10和25/72,χ2=7.485,P=0.006),更容易出现Coombs'试验阳性(7/8和14/29,x2=3.931,P=0.047),肾脏病理分型以Ⅳ或Ⅳ+Ⅴ型者(8/9和6/30,χ2=14.278,P<0.01)居多.疗效不佳组患儿的血红蛋白(P=0.013)、血浆白蛋白(P=0.001)、血浆球蛋白(P=0.004)、内生肌酐清除率(Ccr) (P<0.01)、血钙(P=0.040)及血免疫球蛋白(P=0.006)均低于治疗有效组,血钾(P=0.011)、血磷(P=0.035)、尿蛋白定量(24 h)(P=0.001)和SLEDAI评分(P=0.002)均高于治疗有效组.内生肌酐清除率<75.91 ml ·min-1·1.73 m-2、尿蛋白定量(24 h)>1 771.5 mg和SLEDAI> 11.5可作为诊断截断点预测SLE患儿发生疗效不佳.Logistic回归分析显示,Ccr是影响SLE预后的危险因素(P=0.043),OR为23.9,95%CI为1.10~516.8.结论 SLE男童的疗效相对较差,内生肌酐清除率<75.91 ml·min-1· 1.73 m-2、尿蛋白定量(24 h)>1 771.5 mg和SLEDAI>1 1.5可作为预测SLE患儿疗效不佳的定量指标,有自身免疫性溶血性贫血的SLE患儿也可能会出现疗效不佳。 Objective To investigate the risk factors for poor response to treatment in juvenile-onset systemic lupus erythematosus (SLE).Methods The clinical manifestations,treatment and follow up data of the initial onset SLE patients in our hospital were collected retrospectively.According to the response to treatment after 6 months,patients were divided in two groups.One was treatment effective group,and the other was poor response group.The data of the two groups were analyzed by SPSS 16.0 Counted data were analyzed by Chi-square test.Measurement data were analyzed by t-test.The areas under ROC curve of the measurement data which had statistical significance were calculated and further Logistic regression analysis were made.Results In all of the 82 patients with first onset SLE,72 patients were in the treatment effective group and 10 were in the poor response group.Boy gender (5/10 & 12/72,χ2=5.937,P=0.015),edema (10/10 & 25/72,χ2=15.294,P〈0.O1) and serositis (8/10 & 25/72,χ2=7.485,P=0.006),higher positive rate of Coombs' test (7/8 & 14/29,x2=3.931,P=0.047) and histological class Ⅳ or Ⅳ+Ⅴ of lupus nephritis (8/9 & 6/30,χ2=14.278,P〈0.01) were more common in the poor response group.The level of hemoglobin (P=0.013),serum albumin (P=0.001) and globulin (P=0.004),creatinine clearance (P〈0.01),serum calcium (P=0.040) and immunoglobulin (P=0.006) of the patients in the poor efficacy group were lower than those of patients in the treatment effective group.The level of serum potassium (P=0.011),serum phosphorus (P=0.035),24 hours proteinuria (P=0.001) and SLEDAI (P=0.002) of the patients in the poor response were higher than those patients in the treatment effective group.The creatinine clearance was lower than 75.91 ml·min-1· 1.73 m-2,24 hours proteinuria was higher than 1 771.5 mg and SLEDAI was higher than 11.5 could be the diagnostic cutoff value to predict the poor response to treatment in juvenile-onset SLE patients.The results of Logistic regression analysis showed creatinine clearance lower than 75.91 ml ·min-1· 1.73 m-2 was the risk factor that could influence the outcome of SLE patients (P=0.043).The OR was 23.9 and 95%CI was from 1.10 to 516.8.Conclusion In juvenile-onset SLE patients,boys have poor response to treatment.The creatinine clearance lower than 75.91 ml·min 1· 1.73 m-2,24 hours proteinuria higher than 1 771.5 mg and SLEDAI higher than 11.5 can predict the poor response to treatment in juvenile-onset SLE patients.In addition,the SLE patients with autoimmune hemolytic anemia may have poor response to treatment.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2014年第9期627-631,共5页 Chinese Journal of Rheumatology
关键词 红斑狼疮 系统性 危险因素 儿童 Lupus erythematosus, systemic Risk factors Child
  • 相关文献

参考文献18

  • 1Morgan T, Watson L, McCann L, et al. Children and adoles- cents with SLE: not just little adults[J]. Lupus, 2013, 22: 1309- 1319.
  • 2Watson L, Leone V, Pilkington C, et al. Disease activity, sever- ity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort[J]. Arthritis Rheum, 2012, 64: 2356- 2365.
  • 3Mok CC, Kwok RC, Yip PS. Effect of renal disease on the stan- dardized mortality ratio and life expectancy of patients with systemic lupus erythematosus [J]. Arthritis Rheum, 2013, 65: 2154-2160.
  • 4Nived O, Hallengren CS, Aim P, et al. An observational study of outcome in SLE patients with biopsy-verified glomerulonephri- tis between 1986 and 2004 in a defined area of southern Swe- den: the clinical utility of the ACR renal response criteria and predictom for renal outcome [J]. Scand'J Rheumatol, 2013, 42: 383-389.
  • 5系统性红斑狼疮诊断及治疗指南[J].中华风湿病学杂志,2010,14(5):342-346. 被引量:577
  • 6Liang MH, Schur PH, Fortin P, et al. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical triMs[J]. Arthritis Rheum, 2006, 54: 421-432.
  • 7Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune throm-boeytopenic purpura of adults and children: report from an inter- national working group[J]. Blood, 2009, 113: 238-393.
  • 8Bussone G, Ribeiro E, Dechartres A, et al. Efficacy and safety of fituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases[J]. Am J Hematol,2009, 84: 153-157.
  • 9Bang SY, Lee CK, Kang YM, et al. Multicenter retrospective analysis of the effectiveness and safety of rituximab in Korean patients with refractory systemic lupus erythematosus[J]. Autoim- mune Dis, 2012, 2012: 565039.
  • 10Ohta A, Nagai M, Nishina M, et al. Age at onset and gender distribution of systemic lupus erythematosus, polymyositis/der- matomyositis, and systemic sclerosis in Japan[J]. Mod Rheuma- tol, 2013, 23: 759-764.

共引文献576

同被引文献68

引证文献3

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部